EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation

Lorena Camargo-Ayala, Mauricio Bedoya, Albert Dasí, Merten Prüser, Sven Schütte, Luis Prent-Peñaloza, Francisco Adasme-Carreño, Aytug K Kiper, Susanne Rinné, Paola Andrea Camargo-Ayala, Paula A Peña-Martínez, Alfonso Bueno-Orovio und 13 weitere

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.108387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Lorena Camargo-Ayala und 24 weiteren Autor:innen. Beteiligte Einrichtung: Doctorado en Ciencias Mención I + D de Productos Bioactivos, Instituto de Química de Recursos Naturales, Laboratorio de Síntesis Orgánica, Universida…. Hauptthemen laut MEDLINE: Atrial Fibrillation, NAV1.5 Voltage-Gated Sodium Channel, Kv1.5 Potassium Channel, Drug Design. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Deutsche Forschungsgemeinschaft, Deutsche Herzstiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation (AF) involves electrical remodeling of the atria, with ion channels such as Na V 1.5, K V 1.5, and TASK-1 playing crucial roles. This study investigates acetamide-based compounds designed as multi-target inhibitors of these ion channels to address AF. Compound 6f emerged as the most potent in the series, demonstrating a strong inhibition of TASK-1 (IC 50 ∼ 0.3 μM), a moderate inhibition of Na V 1.5 (IC 50 ∼ 21.2 μM) and a subtle inhibition of K V 1.5 (IC 50 ∼ 81.5 μM), alongside unexpected activation of TASK-4 (∼ 40% at 100 μM). Functional assays on human atrial cardiomyocytes from sinus rhythm (SR) and patients with AF revealed that 6f reduced action potential amplitude in SR (indicating Na V 1.5 block), while in AF it increased action potential duration (APD), reflecting high affinity for TASK-1. Additionally, 6f caused hyperpolarization of the resting membrane potential in AF cardiomyocytes, consistent with the observed TASK-4 activation. Mathematical modeling further validated its efficacy in reducing AF burden. Pharmacokinetic analyses suggest favorable absorption and low toxicity. These findings identify 6f as a promising multi-target therapeutic candidate for AF management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationNAV1.5 Voltage-Gated Sodium ChannelKv1.5 Potassium ChannelDrug DesignPotassium Channels, Tandem Pore DomainNerve Tissue ProteinsAnti-Arrhythmia AgentsPotassium Channel BlockersHumansMyocytes, CardiacAction Potentials

Stichwörter der Autor:innen

K(2)P channelsK(V)1.5Na(V)1.5Polypharmacologyatrial fibrillationion channelsmulti-target inhibitors

Substanzen

NAV1.5 Voltage-Gated Sodium ChannelKv1.5 Potassium ChannelPotassium Channels, Tandem Pore DomainNerve Tissue ProteinsSCN5A protein, humanKCNA5 protein, humanAnti-Arrhythmia Agentspotassium channel subfamily K member 3Potassium Channel Blockers

Autor:innen und Institutionen

  • Doctorado en Ciencias Mención I + D de Productos Bioactivos, Instituto de Química de Recursos Naturales, Laboratorio de Síntesis Orgánica, Universidad de Talca, Talca, Chile.
  • Centro de Investigación de Estudios Avanzados del Maule (CIEAM), Vicerrectoría de Investigación y Postgrado, Universidad Católica del Maule, Talca, Chile; Laboratorio de Bioinformática y Química Computacional (LBQC), De…
  • Department of Computer Science, British Heart Foundation Centre of Research Excellence, University of Oxford, Oxford, UK.
  • Department of Cardiology, University of Heidelberg, Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), partner site Heidelberg /Mannheim, University of Heidelberg, Heidelberg, Germany; HCR, Heidelber…
  • Institute for Physiology and Pathophysiology, Philipps-University Marburg, Marburg, Germany.
  • Departamento de Ciencias Químicas, Facultad de Ciencias Exactas, Universidad Andrés Bello, Viña del Mar, Chile.

Förderung

  • Wellcome Trust
  • Deutsche Forschungsgemeinschaft
  • Deutsche Herzstiftung
  • Else Kröner-Fresenius-Stiftung
  • Deutsches Zentrum für Herz-Kreislaufforschung

Zitieren

APA

Camargo-Ayala, L., Bedoya, M., Dasí, A., Prüser, M., Schütte, S., Prent-Peñaloza, L., Adasme-Carreño, F., Kiper, A. K., Rinné, S., Camargo-Ayala, P. A., Peña-Martínez, P. A., Bueno-Orovio, A., Varela, D., Wiedmann, F., Márquez Montesinos, J. C. E., Mazola, Y., Venturini, W., Zúñiga, R., Zúñiga, L., …, & González, W. (2025). Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108387

Vancouver

Camargo-Ayala L, Bedoya M, Dasí A, Prüser M, Schütte S, Prent-Peñaloza L, et al. Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108387

BibTeX
@article{CamargoAyala2025,
  author = {Camargo-Ayala, Lorena and Bedoya, Mauricio and Dasí, Albert and Prüser, Merten and Schütte, Sven and Prent-Peñaloza, Luis and Adasme-Carreño, Francisco and Kiper, Aytug K and Rinné, Susanne and Camargo-Ayala, Paola Andrea and Peña-Martínez, Paula A and Bueno-Orovio, Alfonso and Varela, Diego and Wiedmann, Felix and Márquez Montesinos, José C E and Mazola, Yuliet and Venturini, Whitney and Zúñiga, Rafael and Zúñiga, Leandro and Schmidt, Constanze and Rodriguez, Blanca and Ravens, Ursula and Decher, Niels and Gutiérrez, Margarita and González, Wendy},
  title = {Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.108387}
}
Kostenlos starten →